Stocks
Zynerba Pharmaceuticals (ZYNE) EV/EBITDA US GAAP (year values) |
|||||||||
| FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | LTM ? | CAGR 5 years ? | |||
| EV/EBITDA | ? | 0.35 | -1.85 | -0.58 | -1.27 | 1.45 | -0.77 | ||
| Changes by years, y/y, % | -81% | -622% | -69% | +119% | -215% | -5.3% | |||
Zynerba Pharmaceuticals. EV/EBITDA
Zynerba Pharmaceuticals. EV/EBITDA, changes, %
Zynerba Pharmaceuticals (ZYNE) EV/EBITDA US GAAP (quarter values) |
||||||||
| FY2022Q2 | FY2022Q3 | FY2022Q4 | FY2023Q1 | FY2023Q2 | LTM ? | |||
| EV/EBITDA | ? | 0.40 | 0.68 | 1.44 | 0.64 | 0.51 | -0.77 | |
| Changes by years, y/y, % | -112% | -127% | -208% | -278% | +26% | |||
| Changes by quarters, q/q, % | -212% | +68% | +113% | -56% | -21% | |||
